Workflow
吉星新能源(03395.HK)拟折让约5.71%配发1289.1万股 净筹73.19万加元
Ge Long Hui· 2025-09-05 14:52
Group 1 - The company, Jixing New Energy (03395.HK), announced a subscription agreement on September 5, 2025, to issue 12,891,250 subscription shares at a price of HKD 0.33 per share [1] - The subscription price of HKD 0.33 represents a discount of approximately 5.71% compared to the closing price of HKD 0.35 on the Hong Kong Stock Exchange on the same date [1] - The estimated net proceeds from the subscription, after deducting related expenses, will be approximately CAD 731,900, with a net subscription price of about HKD 0.322 per share [1]
标准发展集团(01867.HK)委任赵昌盛及徐兆鸿为独立非执行董事
Ge Long Hui· 2025-09-05 14:52
格隆汇9月5日丨标准发展集团(01867.HK)公告,于2025年9月5日,(i)梁荣进已通知公司,彼拟于应届股 东周年大会上退任独立非执行董事,且不会重选连任;及(ii)严兵已通知公司,彼拟于应届股东周年大 会上退任独立非执行董事,且不会重选连任。董事会进一步宣布,董事会建议于2025年9月5日于股东周 年大会上委任赵昌盛及徐兆鸿为独立非执行董事。 ...
天玺曜11(01010):陈霆畧获委任为独立非执行董事兼核数委员会成员
智通财经网· 2025-09-05 14:50
智通财经APP讯,天玺曜11(01010)发布公告,陈霆畧先生(陈先生)已获委任为独立非执行董事兼核数委 员会成员,以及为薪酬委员会及提名委员会各自的主席,自2025年9月5日起生效。 ...
猫屎咖啡控股(01869)与银柘科技订立谅解备忘录
智通财经网· 2025-09-05 14:50
Core Viewpoint - The company has entered into a non-binding memorandum of understanding with Yinzhe Technology (Guangzhou) Co., Ltd, aiming to explore collaboration opportunities and optimize its strategic planning [1] Group 1 - The memorandum will leverage the strengths of both parties' platform resources [1] - Further discussions and formal agreements are needed to finalize the cooperation terms [1] - The board believes this memorandum will enhance the company's existing strategic planning and provide new development opportunities in various fields [1]
天玺曜11:陈霆畧获委任为独立非执行董事兼核数委员会成员
Zhi Tong Cai Jing· 2025-09-05 14:48
天玺曜11(01010)发布公告,陈霆畧先生(陈先生)已获委任为独立非执行董事兼核数委员会成员,以及为 薪酬委员会及提名委员会各自的主席,自2025年9月5日起生效。 ...
猫屎咖啡控股与银柘科技订立谅解备忘录
Zhi Tong Cai Jing· 2025-09-05 14:48
Core Viewpoint - Cat Poop Coffee Holdings (01869) has signed a non-binding memorandum of understanding with Yinzhe Technology (Guangzhou) Co., Ltd, aiming to explore collaboration opportunities and optimize the company's strategic planning [1] Group 1 - The memorandum allows both parties to leverage their platform resources for potential cooperation [1] - The board believes that this memorandum will enhance the company's existing strategic planning and provide new development opportunities [1] - The collaboration may expand the company's growth in supply chain, product sales, big data, and digital technology services [1]
梦东方附属完成收购东置控股
Zhi Tong Cai Jing· 2025-09-05 14:48
清盘人谨此宣布,买卖协议项下的先决条件已达成,且收购事项于2025年9月4日根据买卖协议的条款及 条件完成。于完成后,目标公司已成为公司的间接全资附属公司,其财务业绩、资产及负债将并入集团 的财务报表。 梦东方(00593)发布公告,内容有关公司附属拟1300万港元收购东置控股全部已发行股本。 ...
国开国际投资:2025年中期亏损1168.2万港元
Sou Hu Cai Jing· 2025-09-05 14:47
Core Viewpoint - The company operates primarily in investment activities, focusing on securities related to currency markets, both listed and unlisted equity and debt securities globally [9]. Financial Performance - In the first half of 2025, the company's average return on equity was -1.18%, an increase of 10.32 percentage points compared to the same period last year [14]. - The net cash flow from operating activities for the first half of 2025 was -8.1997 million HKD, while the net cash flow from financing activities was -5.1932 million HKD, and the net cash flow from investing activities was 9.0978 million HKD [16]. Asset and Liability Changes - As of the first half of 2025, the company's right-of-use assets decreased by 26.09%, with a 0.46 percentage point decline in the proportion of total assets [22]. - The company's lease liabilities decreased by 51.9%, resulting in a 0.47 percentage point decline in the proportion of total assets [25]. - The company's current ratio was 24.27 in the first half of 2025 [29].
京东健康:2025年中期净利润25.96亿元 同比增长27.45%
Sou Hu Cai Jing· 2025-09-05 14:47
Core Insights - The company primarily engages in the "Internet + Healthcare" ecosystem, providing pharmaceutical and health products, internet medical services, health management, and smart healthcare solutions, mainly in the domestic market [6] Financial Performance - The company's revenue and net profit growth rates have shown fluctuations over the years, with significant changes noted in 2023 and projections for 2024 and 2025 [9][10] - In the first half of 2025, the company reported a revenue composition of 293.3 billion from pharmaceutical and health product sales, with additional service income from platforms and advertising [10] - The average return on equity for the first half of 2025 was 4.62%, an increase of 0.62 percentage points compared to the same period last year [16] Cash Flow and Assets - The net cash flow from operating activities for the first half of 2025 was 62.45 billion, while financing and investment activities showed negative cash flows [19] - Significant changes in assets include a 58.12% decrease in trading financial assets and a 27.6% increase in inventory, affecting the overall asset composition [27] Liabilities and Ratios - The company experienced a 30.43% increase in accounts payable and a 26.62% rise in other payables, impacting the total asset ratio [30] - As of the first half of 2025, the current ratio was 2.92 and the quick ratio was 2.55, indicating strong liquidity [33]
天玺曜11(01010.HK):陈霆畧获委任为独立非执行董事
Ge Long Hui· 2025-09-05 14:47
格隆汇9月5日丨天玺曜11(01010.HK)公告,董事会谨此宣布,陈霆畧已获委任为独立非执行董事兼核数 委员会成员,以及为薪酬委员会及提名委员会各自的主席,自2025年9月5日起生效。 ...